CagriSema may be easier to understand as a semaglutide-plus-amylin strategy
It is not approved by the FDA for veterinary use and should not be administered to animals outside of approved research protocols
Mechanism of Action (Based on Research) The combination of BPC-157 and TB-500 has drawn interest in preclinical studies due to their complementary mechanisms in supporting tissue repair, cellular regeneration, and inflammation control
In January 2024, the FDA proposed a rule that would prevent BPC-157 from being used in compounding, classifying it alongside other peptides that lack adequate safety and efficacy data for compounded use 3
Dr Israetel has contributed to numerous peer-reviewed scientific journals and presented his research at various conferences
(6) Hyun Keol Pyo, Hyeon Gyeong Yoo, Chong Hyun Won, Seung Ho Lee, et al (2007) The effect of tripeptide-copper complex on human hair growth in vitro Archives of Pharmacal Research, 2007 Jul, Volume 30 (Issue 7), Pages 834-9